Cite
HARVARD Citation
Lara, P. et al. (2016). SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. Journal of thoracic oncology. 11 (3), p. . [Online].